Location History:
- Tokushima, JP (2017)
- Osaka, JP (2017 - 2020)
Company Filing History:
4 out of 61 
2 out of 846 
Years Active: 2017-2025
Title: The Innovative Contributions of Shinji Sogo
Introduction
Shinji Sogo is a prominent inventor based in Osaka, Japan. He has made significant contributions to the field of cancer immunology, particularly through his innovative methods for activating helper T cells. With a total of four patents to his name, Sogo's work is paving the way for advancements in immunotherapy.
Latest Patents
One of Sogo's latest patents is a method for activating helper T cells. This invention involves the activation of helper T cells by adding a WT1 peptide to antigen presenting cells. The WT1 peptide is designed to bind to various MHC class II molecules, including HLA-DRB1*0101, HLA-DRB1*0401, HLA-DRB1*0403, HLA-DRB1*0406, HLA-DRB1*0803, HLA-DRB1*0901, HLA-DRB1*1101, HLA-DRB3*0202, HLA-DRB4*0101, HLA-DPB1*0201, and HLA-DPB1*0301. This innovative approach has the potential to enhance the effectiveness of cancer treatments.
Career Highlights
Throughout his career, Shinji Sogo has worked with notable organizations, including the International Institute of Cancer Immunology and Otsuka Pharmaceutical Company. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Sogo has collaborated with esteemed colleagues such as Haruo Sugiyama and Yoshihiro Goto. These partnerships have further enriched his research and development efforts in cancer immunology.
Conclusion
Shinji Sogo's innovative work in activating helper T cells represents a significant advancement in cancer immunotherapy. His contributions are vital to the ongoing efforts to improve treatment options for patients.